Hi all,
Not here much, and just read the financials.
Key highlights for me:
"As at December 31 2022, the Company had cash and cash equivalents of $16,980,472 representing a decrease of $18,279,173 from December 31, 2021. This decrease is primarily due to $28,333,273 of cash used in operating activities, $12,123,408 of cash provided by investing activities and $2,069,308 of cash used in financing activities." Source SEDAR.com
So we read that Cash and cash equivalents
16,980,472
And a decrease of (18,279,173) or -52%
So it looks like, IMO, a cash raise, and dilution will be required, if the cash burn is 18 m illion /year and this is BEFORE the more costly phase 1/2 trials have started
This raised the question Why they were buying back stock?
Hmmmmm
Lets see?
Any thoughts?
Is that loud flushing sound the further dilution coming?
all IMO, do your own DD